Skye Bioscience, Inc. (SKYE)
NASDAQ: SKYE · Real-Time Price · USD
0.873
-0.058 (-6.18%)
Apr 29, 2026, 12:56 PM EDT - Market open
Skye Bioscience Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 5.88 | 68.42 | 1.26 | 1.24 | 8.98 | Upgrade
|
| Short-Term Investments | 19.85 | - | - | 0.07 | - | Upgrade
|
| Cash & Short-Term Investments | 25.74 | 68.42 | 1.26 | 1.32 | 8.98 | Upgrade
|
| Cash Growth | -62.38% | 5345.15% | -4.72% | -85.32% | 263.77% | Upgrade
|
| Other Receivables | 0.01 | 0.01 | 0.7 | 0.18 | - | Upgrade
|
| Receivables | 0.01 | 0.01 | 0.7 | 0.18 | - | Upgrade
|
| Prepaid Expenses | 0.5 | 0.2 | 0.19 | 0.78 | 0.57 | Upgrade
|
| Restricted Cash | - | - | 9.08 | 0 | 0 | Upgrade
|
| Other Current Assets | 0.84 | 2.2 | 0.42 | 6.66 | 0.06 | Upgrade
|
| Total Current Assets | 27.09 | 70.83 | 11.65 | 8.94 | 9.61 | Upgrade
|
| Property, Plant & Equipment | 1.17 | 1.88 | 0.28 | 0.16 | 0.23 | Upgrade
|
| Other Long-Term Assets | 0.05 | 0.05 | 0.01 | 0.01 | 0.01 | Upgrade
|
| Total Assets | 28.31 | 72.76 | 11.94 | 9.11 | 9.86 | Upgrade
|
| Accounts Payable | 2.03 | 0.57 | 0.96 | 1.79 | 0.9 | Upgrade
|
| Accrued Expenses | 3.91 | 1.77 | 2.06 | 1.12 | 0.9 | Upgrade
|
| Short-Term Debt | - | - | 4.37 | 0.06 | - | Upgrade
|
| Current Portion of Long-Term Debt | - | - | - | 1.85 | 1.97 | Upgrade
|
| Current Portion of Leases | 0.19 | 0.18 | 0.07 | 0.08 | 0.08 | Upgrade
|
| Other Current Liabilities | 2.07 | 1.82 | 6.44 | 7.22 | 0.06 | Upgrade
|
| Total Current Liabilities | 8.21 | 4.34 | 13.9 | 12.12 | 3.91 | Upgrade
|
| Long-Term Leases | 0.08 | 0.27 | 0.17 | - | 0.08 | Upgrade
|
| Total Liabilities | 8.29 | 4.61 | 14.07 | 12.12 | 3.99 | Upgrade
|
| Common Stock | 0.03 | 0.03 | 0.01 | 0 | 0.48 | Upgrade
|
| Additional Paid-In Capital | 206.87 | 199.07 | 102.24 | 63.73 | 52.64 | Upgrade
|
| Retained Earnings | -186.87 | -130.95 | -104.38 | -66.74 | -47.26 | Upgrade
|
| Total Common Equity | 20.02 | 68.15 | -2.13 | -3.01 | 5.86 | Upgrade
|
| Shareholders' Equity | 20.02 | 68.15 | -2.13 | -3.01 | 5.86 | Upgrade
|
| Total Liabilities & Equity | 28.31 | 72.76 | 11.94 | 9.11 | 9.86 | Upgrade
|
| Total Debt | 0.27 | 0.46 | 4.62 | 1.98 | 2.14 | Upgrade
|
| Net Cash (Debt) | 25.46 | 67.96 | -3.36 | -0.66 | 6.85 | Upgrade
|
| Net Cash Growth | -62.53% | - | - | - | 604.71% | Upgrade
|
| Net Cash Per Share | 0.64 | 1.86 | -0.48 | -0.30 | 4.21 | Upgrade
|
| Filing Date Shares Outstanding | 33.38 | 30.97 | 28.06 | 3.89 | 1.98 | Upgrade
|
| Total Common Shares Outstanding | 33.38 | 30.97 | 12.35 | 3.65 | 1.9 | Upgrade
|
| Working Capital | 18.89 | 66.49 | -2.25 | -3.18 | 5.7 | Upgrade
|
| Book Value Per Share | 0.60 | 2.20 | -0.17 | -0.82 | 3.08 | Upgrade
|
| Tangible Book Value | 20.02 | 68.15 | -2.13 | -3.01 | 5.86 | Upgrade
|
| Tangible Book Value Per Share | 0.60 | 2.20 | -0.17 | -0.82 | 3.08 | Upgrade
|
| Machinery | 1.65 | 1.64 | 0.12 | - | - | Upgrade
|
| Leasehold Improvements | 0.02 | 0.02 | 0.01 | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.